• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C TOTAL BILIRUBIN REAGENT KIT; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C TOTAL BILIRUBIN REAGENT KIT; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 04V5121
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/30/2022
Event Type  malfunction  
Event Description
The customer observed falsely elevated alinity c total bilirubin results for eight patients generated on the alinity c analyzer.The samples were repeated on the roche analyzer which generated normal results.The customer then ran controls on the alinity c analyzer, and the controls were also out of range high.The customer performed daily maintenance, repeated the controls and controls were back in range.The customer repeated the eight samples again and the results were within the normal range.The customer provided the following data for 3 patients: normal range 3.4 to 20.5 umol/l on (b)(6) 2022 sid (b)(6) initial result = 165.3 umol/l, repeat result post maintenance = 14.2 umol/l, roche result = 13.3 umol/l on (b)(6) 2022 sid (b)(6) initial result = 177.4 umol/l, repeat result post maintenance = 4.6 umol/l, roche result = 3.2 umol/l on (b)(6) 2022 (b)(6) initial result = 67.3 umol/l, repeat result post maintenance = 6.4 umol/l, roche result = 5.4 umol/l no impact to patient management was reported.
 
Manufacturer Narrative
Patient identifier: sids are: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The complaint investigation for falsely elevated alinity c total bilirubin results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, field data review, and labeling review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot number 60971uq11 and the complaint issue.The overall performance of the alinity c total bilirubin assay was reviewed using field data from customers worldwide.The median population result for lot 60971uq11 is within the established baseline, indicating the reagent lot is performing acceptably.Labeling was reviewed and sufficiently addresses the customer's issue.With the information provided in the complaint and this investigation, the exact cause of the shifted alinity c total bilirubin results cannot be determined.However, daily maintenance accomplishes several actions that may be a cause of shifted results.Pipettor lines are flushed removing bubbles and accumulated debris if present.The incubator water bath is exchanged along with cleaning of the pipettor probes and mixers.Each of these items are potential sources of error when results are observed to be impacted.Based on our investigation, no systemic issue or deficiency with the alinity c total bilirubin assay for lot 60971uq11 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C TOTAL BILIRUBIN REAGENT KIT
Type of Device
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key15544588
MDR Text Key303559636
Report Number3002809144-2022-00349
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740158415
UDI-Public00380740158415
Combination Product (y/n)N
Reporter Country CodeTC
PMA/PMN Number
K121985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2023
Device Model Number04V5121
Device Catalogue Number04V51-21
Device Lot Number60971UQ11
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/03/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY C PROCESSING MODU, 03R67-01, (B)(6); ALNTY C PROCESSING MODU, 03R67-01, (B)(6)
-
-